This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Catalyst Pharmaceutical Partners Inc (CPRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 9.10M 6.23M 7.91M 6.03M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 3.72M 0.00 0.00 0.00
Total Current Assets 43.83M 25.32M 16.73M 6.23M
Property, Plant & Equipment, Gross 184.57K 133.07K 123.64K 71.26K
Accumulated Depreciation & Depletion 113.19K 92.45K 69.96K 59.07K
Property, Plant & Equipment, Net 71.38K 40.63K 53.68K 12.19K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 8.89K 8.89K 8.89K 8.89K
Total Non-Current Assets 80.26K 49.52K 62.57K 21.07K
Liabilities & Shareholder Equity
Total Assets 43.91M 25.37M 16.79M 6.25M
Accounts Payable 1.81M 850.79K 1.37M 263.93K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 5.86M 2.14M 1.65M 833.80K
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 21.88K 0.00
Other Non-Current Liabilities 2.81M 1.84M 498.59K 1.65M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.81M 1.84M 520.46K 1.65M
Total Liabilities 8.67M 3.98M 2.17M 2.49M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 35.24M 21.39M 14.62M 3.76M
Common Par 69.12K 54.13K 41.42K 24.70K
Additional Paid In Capital 105.02M 75.67M 56.76M 41.84M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -69.84M -54.33M -42.18M -38.10M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 35.24M 21.39M 14.62M 3.76M
Total Equity 35.24M 21.39M 14.62M 3.76M
Total Liabilities & Stock Equity 43.91M 25.37M 16.79M 6.25M
Total Common Shares Outstanding 69.12M 54.13M 41.42M 24.70M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 64.14M 45.45M 30.03M 21.73M
Diluted Weighted Shares Outstanding 64.14M 45.45M 30.03M 21.73M
Number of Employees 12 7 6 6
Number of Part-Time Employees 0 0 0 0
CPRX News

CPRX Catalyst Pharmaceutical Partners Inc

Analysts Ratings for CPRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CPRX ANALYST REPORT

Brokerage Partners

CPRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs